New drug cocktail aims to tackle tough leukemias
Disease control
Recruiting now
This early-phase trial is testing a new drug called ABL001 together with three other medicines (dasatinib, prednisone, and blinatumomab) in people with BCR-ABL positive B-cell acute lymphoblastic leukemia or chronic myeloid leukemia in blast crisis. The study aims to find the saf…
Phase: PHASE1 • Sponsor: Marlise Luskin, MD • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC